CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
40 hedge funds and large institutions have $63.1M invested in Cellular Biomedicine Group, Inc. in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $16K
Holders
40
Holding in Top 10
–
Calls
–
Puts
$16K
Top Buyers
| 1 | +$3.5M | |
| 2 | +$687K | |
| 3 | +$524K | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$461K |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$436K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$531K | |
| 3 | -$149K | |
| 4 |
Bank of New York Mellon
New York
|
-$88.5K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$87K |